Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical statistics
15 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Mar 31, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 1688.1%
- 10.8%
GrowthIndustry
- EPS Growth (YoY)
- -138.3%
- -24.1%
EfficiencyIndustry
- Employee Count
- 12
- 75
Income statement (TTM)Industry
- Pretax Income
- -$6.23M
- -$14.23M
Balance sheetIndustry
- Net Cash (Debt)
- $7.19M
- $15.31M
- Net Cash Per Share
- $3.14
- $0.66
Cash flow (TTM)Industry
- Capital Expenditures
- -$229
- -$1.07M
- FCF Per Share
- -$3.55
- -$0.41
Taxes and interestIndustry
- Interest Expense
- $9.52K
- $3.07M
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | PBMWW | S&P 500 | Difference | PBMWW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -44.3% | -0.9% | −43.4 pts | ||
| 3 months | -66.1% | +2.1% | −68.2 pts | ||
| Year to date | -36.8% | +11.7% | −48.4 pts | ||
| 1 year | -46.8% | +12.4% | −59.2 pts | ||
| 3 years | -31.6% | +88.6% | −120.1 pts | -11.9% | +23.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M PBMWW shares were sold short on Oct 15, 2026, down 1.7% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 89.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 17,628 | -1.7% | 34,691 | 1.0 |
| Sep 30, 2026 | 17,933 | +11.5% | 45,758 | 1.0 |
| Sep 15, 2026 | 16,090 | -16.4% | 17,128 | 1.0 |
| Aug 31, 2026 | 19,253 | -20.6% | 58,471 | 1.0 |
| Aug 14, 2026 | 24,244 | +79.3% | 19,718 | 1.2 |
| Jul 31, 2026 | 13,525 | +0.2% | 10,387 | 1.3 |
| Jul 15, 2026 | 13,498 | +0.6% | 1,784 | 7.6 |
| Jun 30, 2026 | 13,416 | +0.9% | 14,511 | 1.0 |
| Jun 15, 2026 | 13,290 | -7.0% | 36,499 | 1.0 |
| May 29, 2026 | 14,291 | -6.6% | 20,385 | 1.0 |
| May 15, 2026 | 15,296 | -14.8% | 7,354 | 2.1 |
| Apr 30, 2026 | 17,956 | +1.7% | 274,128 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.